Filing Details

Accession Number:
0001203311-21-000064
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-08-18 20:29:24
Reporting Period:
2021-08-16
Accepted Time:
2021-08-18 20:29:24
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1060736 Seagen Inc. SGEN Biological Products, (No Disgnostic Substances) (2836) 911874389
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1167496 B Clay Siegall 21823 30Th Drive Se
Bothell WA 98021
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-08-16 2,789 $154.55 712,420 No 4 S Direct
Common Stock Acquisiton 2021-08-16 30,821 $0.00 743,241 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Acquisiton 2021-08-16 642 $0.00 642 $155.87
Common Stock Non-Qualified Stock Option (right to buy) Acquisiton 2021-08-16 74,549 $0.00 74,549 $155.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
642 2031-08-16 No 4 A Direct
74,549 2031-08-16 No 4 A Direct
Footnotes
  1. Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  2. Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting.
  3. These shares represent restricted stock units and will be settled in common stock upon vesting.
  4. Shares shall vest at a rate of 25% on each anniversary of August 15, 2021 until all shares are fully vested at the end of four years.
  5. Options shall vest at a rate of 25% one year from grant date and monthly thereafter until all options are fully vested four years from grant date.